Patent details
300731 Product Name: Ombitasvir of een farmaceutisch aanvaardbaar zout daarvan
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 300731
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP2368890
- Status:
- SPC granted but not yet in force
- Application number:
- 300731
- Procedural language:
- Dutch
- First Applicant Residence Country:
Marketing Authorization
- Marketing Authorization Number:
- EU/1/14/982
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 19/01/2015
- Marketing Authorization Country:
- European Union (EU)
Dates
- Filing date:
- 08/04/2015
- First Marketing Authorization date:
- 19/01/2015
- Grant date:
- 07/01/2016
- Activation date:
- 10/06/2030
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 08/04/2015
- SPC/SPC Extension Expiration Date:
- 18/01/2030
- Lapsed By Expiration Date:
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 27/12/2024
- Name:
- AbbVie Manufacturing Management Unlimited Company
- Address:
- 70 Sir John Rogerson's Quay, Dublin 2, Ireland (IE)
Historical Applicant/holder
- From:
- 27/12/2024
- To:
- 27/12/2024
- Name:
- AbbVie Ireland Unlimited Company
- Address:
- 70 Sir John Rogerson's Quay, Dublin 2, Ireland (IE)
- From:
- 08/04/2015
- To:
- 27/12/2024
- Name:
- AbbVie Bahamas Limited
- Address:
- Sassoon House Shirley Street & Victoria Avenue, NEW PROVIDENCE, NASSAU, Bahamas (BS)
Agent
- Name:
- ir. H.A. Witmans c.s.
- From:
- 08/04/2015
- Address:
- V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- CO
- Journal edition number:
- 02/25
- Publication date:
- 08/01/2025
- Description:
- Changes in the Netherlands Patent Register
2
- Bulletin Heading:
- CO
- Journal edition number:
- 02/25
- Publication date:
- 08/01/2025
- Description:
- Changes in the Netherlands Patent Register
3
- Bulletin Heading:
- SPC
- Journal edition number:
- 02/16
- Publication date:
- 13/01/2016
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
- Bulletin Heading:
- SPC
- Journal edition number:
- 2015/17
- Publication date:
- 22/04/2015
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC202402351A
- Date Registered:
- 27/12/2024
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. H.A. Witmans c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- AbbVie Ireland Unlimited Company
- Address:
- 70 Sir John Rogerson's Quay, Dublin 2, Ireland (IE)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC202402351C
- Date Registered:
- 27/12/2024
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. H.A. Witmans c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- AbbVie Manufacturing Management Unlimited Company
- Address:
- 70 Sir John Rogerson's Quay, Dublin 2, Ireland (IE)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Other
- Note:
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 25/01/2016 | Outgoing Correspondence | Decision grant | 1 | /1/3/7/0/0/0400300731/docs/300731_0_outgoingcorrespondence20201125054035470.pdf | ||
| 25/01/2016 | SPC Documents | Certificate SPC | 1 | /1/3/7/0/0/0400300731/docs/300731_6_supplprotectioncertificate20201125054327776.pdf | ||
| 12/06/2015 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /1/3/7/0/0/0400300731/docs/300731_5_incomingcorrespondencepaper20210316035020365.pdf | ||
| 21/04/2015 | Outgoing Correspondence | Outgoing Letter | 2 | /1/3/7/0/0/0400300731/docs/300731_3_outgoingcorrespondence20150421.pdf | ||
| 10/04/2015 | Outgoing Correspondence | Outgoing Letter | 1 | /1/3/7/0/0/0400300731/docs/300731_11_outgoingcorrespondence20150410.pdf | ||
| 09/04/2015 | SPC Documents | Annex SPC | 2 | /1/3/7/0/0/0400300731/docs/300731_1_supplprotectioncertificate20201125043313501.pdf | ||
| 09/04/2015 | Application Form | First filed application form | 3 | /1/3/7/0/0/0400300731/docs/300731_2_applicationform20150409.pdf | ||
| 09/04/2015 | SPC Documents | Annex SPC | 1 | /1/3/7/0/0/0400300731/docs/300731_4_supplprotectioncertificate20201125044450732.pdf | ||
| 09/04/2015 | SPC Documents | Summary of the characteristics of the product | 59 | /1/3/7/0/0/0400300731/docs/300731_7_supplprotectioncertificate20201125043313405.pdf | ||
| 09/04/2015 | SPC Documents | Annex SPC | 1 | /1/3/7/0/0/0400300731/docs/300731_8_supplprotectioncertificate20201125044450644.pdf | ||
| 09/04/2015 | SPC Documents | Marketing Authorization SPC | 3 | /1/3/7/0/0/0400300731/docs/300731_9_supplprotectioncertificate20201125020257444.pdf | ||
| 09/04/2015 | SPC Documents | Annex SPC | 16 | /1/3/7/0/0/0400300731/docs/300731_10_supplprotectioncertificate20201125043313551.pdf |